Vaishali Pharma delivered strong profitability growth in the June 2026 quarter, with net profit rising 16.41% to ₹1.49 crore compared to ₹1.28 crore in the corresponding quarter of the previous year. According to reports from Business Standard, this profit growth occurred despite facing revenue headwinds during the quarter. The latest consolidated results show consolidated net profit at ₹154.54 lakh, including a ₹5.65 lakh share of profit from the associate, demonstrating the company's ability to maintain profitability despite challenging market conditions.
The company's standalone revenue from operations declined 3.62% to ₹22.89 crore in Q1 FY2026, down from ₹23.75 crore in the same quarter of the previous fiscal year. As reported by Business Standard, this revenue contraction indicates challenging market conditions or operational adjustments during the quarter. The latest consolidated figures show consolidated revenue from operations at ₹2,289.14 lakh, with the company noting that the inclusion of associate results from September 2025 is expected to impact future consolidated performance.
The company's operating profit margin (OPM) improved to 6.51% in the June 2026 quarter compared to 5.77% in the corresponding quarter of the previous year. According to the financial data reported by Business Standard, this margin expansion demonstrates enhanced operational efficiency despite the revenue decline. The latest consolidated results show basic and diluted EPS of ₹0.11 (standalone) and ₹0.12 (consolidated) respectively, indicating improved earnings per share performance.
PBDT (Profit Before Depreciation and Tax) remained relatively stable at ₹1.87 crore compared to ₹1.88 crore in the previous year's quarter. Similarly, PBT (Profit Before Tax) declined marginally by 1% to ₹1.73 crore from ₹1.74 crore in Q1 FY2025. As reported by Business Standard, these figures indicate consistent operational performance despite the revenue challenges. The latest consolidated results show PBT at ₹154.54 lakh, reflecting the company's overall financial stability and operational efficiency improvements.
